Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Chronische hepatitis B: wie kan stoppen met nucleos(t)ideanalogen?
jun 2022 | Hepatitis, Hepatologie, Virale infecties